Summary

The global Digestive Tract Stent market is projected to grow from US$ 567 million in 2025 to US$ 893 million by 2032, at a CAGR of 6.7% (2026-2032), driven by critical product segments and diverse end‑use applications.
Digestive Tract Stent refers to an implantable or temporarily indwelling medical device designed to maintain or restore luminal patency within the gastrointestinal tract, seal selected leaks or perforations, and relieve dysphagia, obstruction or other complications caused by benign and malignant disease. The core market covers esophageal, pyloric and duodenal, colonic and rectal stents supplied with dedicated endoscopic or fluoroscopic delivery systems. Most products are self-expanding metal stents manufactured from nitinol or other biocompatible alloys and are offered in uncovered, partially covered and fully covered configurations; selected applications also use polymer stents or biodegradable designs. Key specifications include stent diameter and length, delivery-system profile, radial and axial force, shortening ratio, conformability, radiopacity, covering integrity, migration resistance, repositionability and removability. Clinical use is concentrated in malignant strictures and obstruction, refractory benign strictures, anastomotic complications, fistulas, leaks and perforations.
Key Findings
In 2025, global Digestive Tract Stent production reached approximately 362 K Units, with an average global market price of around US$ 1,565 per unit.
Self-expanding nitinol stents constitute the principal technology platform across major gastrointestinal indications
Esophageal and colorectal stents form the most established commercial product segments
Malignant strictures and obstruction remain the principal clinical demand base
Fully covered designs support removability but require stronger migration-control performance
Global competition combines multinational endoscopy companies with specialized Korean, European and Chinese manufacturers
Market Trends
Digestive tract stents are evolving from basic lumen-expansion devices into indication-specific interventional systems optimized for anatomy, pathology and treatment objectives. Manufacturers are differentiating products through lower-profile delivery systems, controlled deployment, partial recapture, repositioning capability, atraumatic flared ends, anti-migration structures and segment-specific radial and axial force. Esophageal products increasingly emphasize fully covered and removable designs for benign strictures, leaks and fistulas, while malignant cases require reliable patency and resistance to tumor ingrowth. Colonic stents continue to support palliative decompression and, in selected clinical settings, bridge-to-surgery strategies. Pyloric and duodenal products are being optimized for tortuous anatomy and gastric outlet obstruction. The broader technology direction also includes anti-reflux valves, drug-eluting or radioactive concepts, biodegradable stents and lumen-apposing metal stents for specialized transluminal drainage procedures. Hospitals increasingly evaluate the complete system rather than the implant alone, including guidewire compatibility, delivery accuracy, fluoroscopic visibility, physician learning requirements, removal technique and management of adverse events. Clinical evidence, regulatory approvals and region-specific indications are therefore becoming more important competitive variables alongside product design.
Market Dynamics
Drivers
Market demand is supported by the global burden of esophageal, gastric, pancreatic and colorectal malignancies, together with the need for minimally invasive palliation of dysphagia and gastrointestinal obstruction. Stent placement can rapidly restore luminal patency, improve oral intake, decompress the bowel and reduce the need for emergency surgery in appropriately selected patients. Aging populations and greater use of endoscopy and interventional radiology expand the addressable patient pool. Improvements in endoscopic imaging, guidewires, delivery catheters and fluoroscopic navigation also enable treatment of more complex strictures. For patients with advanced cancer, stenting can shorten recovery time and facilitate nutritional support or subsequent oncology treatment. Demand in benign disease is additionally supported by refractory postoperative and anastomotic strictures, leaks and fistulas, provided that removable products and suitable follow-up protocols are available.
Restraints
Adoption is constrained by risks such as migration, restenosis, tissue ingrowth or overgrowth, food impaction, bleeding, pain, reflux and perforation. Fully covered stents reduce tissue ingrowth and facilitate removal but generally require effective anti-migration design, while uncovered products offer stronger anchoring but may be difficult to remove. Clinical outcomes are highly dependent on lesion location, stricture length, tumor characteristics, stent dimensions, operator experience and post-procedure management. The availability of alternative treatments—including balloon dilation, surgery, feeding access, ablative therapy and endoscopic bypass procedures—also limits universal use. Reimbursement, procurement controls and regulatory requirements differ substantially by market, and certain indications or models may not be approved in every jurisdiction. Long qualification cycles and the need for physician training make it difficult for new suppliers to compete solely on price.
Opportunities
Opportunities are concentrated in removable fully covered stents, anti-migration systems, small-diameter delivery devices and products tailored to difficult anatomical locations. Benign esophageal strictures, anastomotic leaks and postoperative fistulas provide development potential where controlled dwell time and atraumatic retrieval can be demonstrated. Colorectal obstruction remains an opportunity for devices that combine flexible navigation, accurate deployment and balanced radial force. Pyloric and duodenal stents can benefit from reduced axial force and improved conformability in curved anatomy. Emerging markets offer expansion potential as therapeutic endoscopy capacity and cancer diagnosis improve. Manufacturers can also create value through broader procedure kits, physician education, clinical-data generation and local technical support. Longer-term innovation opportunities include biodegradable materials, patient-specific geometry, advanced coverings, drug-delivery functions and integration with endoscopic ultrasound-guided interventions, although these technologies require robust clinical and regulatory validation.
Challenges
The central technical challenge is balancing sufficient radial force to open a stricture with low axial force and conformability to reduce pain, pressure injury and perforation risk. Migration resistance must be improved without causing excessive mucosal trauma, while coverings must prevent tissue ingrowth without cracking, delaminating or obstructing side branches. Accurate placement is difficult because self-expanding stents may shorten during deployment, and severe stenosis or tortuous anatomy can restrict delivery-system passage. Product evaluation is complicated by differences in indication, anatomy, operator technique and follow-up duration, which reduce the comparability of clinical studies. Manufacturers must maintain nitinol consistency, covering integrity, radiopaque-marker accuracy and delivery-system reliability across production batches. Product recalls or adverse-event signals can have substantial commercial consequences. Price pressure in centralized procurement markets and increased competition from regional manufacturers create an additional need to balance affordability with evidence, quality systems and post-market surveillance.
Industry Chain Analysis
The upstream industry chain includes medical-grade nitinol wire or tubing, stainless steel and other alloys, silicone, expanded polytetrafluoroethylene or polyurethane covering materials, radiopaque markers, polymer catheters, guidewire-compatible components and precision processing equipment. Core manufacturing processes include laser cutting or wire braiding, heat setting, electropolishing, covering application, marker assembly, delivery-system integration, cleaning, sterilization and package validation. Midstream value creation is concentrated in stent geometry, radial and axial force engineering, covering technology, anti-migration design, deployment control and product consistency. Finished systems are distributed through direct hospital sales, specialized medical-device distributors and regional channel partners. Downstream users include tertiary hospitals, cancer centers, gastroenterology departments, interventional radiology units and gastrointestinal surgery departments. Commercial success depends on clinical evidence, regulatory registration, physician training, procedure support, inventory availability and complaint handling. The highest-value capabilities are not limited to implant manufacturing; they also include delivery-system reliability, indication-specific design, quality traceability and sustained clinical support.
Segment Insights
Esophageal stents represent a mature category used for malignant dysphagia, selected refractory benign strictures, fistulas, leaks and perforations.Intestinal stents include gastroduodenal stents and colorectal stents. Gastroduodenal stents mainly address malignant gastric outlet or duodenal obstruction and require flexibility in curved anatomy. Colorectal stents are used for palliation of malignant obstruction and, under appropriate protocols, decompression before elective surgery. The residual category may cover specialized gastric, anastomotic or transluminal devices when they fall within the defined commercial scope. Biliary and pancreatic duct stents are commercially adjacent products but should be analyzed as separate ductal categories when the study focuses specifically on gastrointestinal luminal stents.
By covering, products are divided into uncovered, partially covered and fully covered stents. Uncovered designs generally offer stronger anchoring and lower migration risk but permit tissue ingrowth. Partially covered designs attempt to balance anchoring with ingrowth control. Fully covered products support sealing and removability but may migrate more readily, encouraging development of flares, anchoring fins, anti-migration struts and modified mesh structures. By manufacturing technology, braided-wire stents provide flexibility and conformability, whereas laser-cut products can offer controlled geometry and limited foreshortening. Additional segmentation by material, delivery method, removability, anti-reflux function and clinical intent provides a more complete framework than anatomical classification alone.
Downstream Market Opportunities
Malignant gastrointestinal strictures and obstruction remain the principal downstream opportunity because stents can rapidly restore patency and support palliative care, nutritional recovery or preparation for subsequent treatment. Esophageal cancer and external tumor compression create demand for covered and partially covered products that control tumor ingrowth and, where necessary, seal fistulas. Gastric outlet and duodenal obstruction require flexible systems capable of passing severe stenoses and curved anatomy. Colorectal cancer obstruction supports both palliative use and selected bridge-to-surgery procedures. Benign disease represents a more selective but technologically attractive market, including refractory strictures, postoperative anastomotic stenosis, leaks and perforations. Hospitals increasingly favor products supported by clear removal protocols, clinical training and adverse-event management. Consequently, suppliers with anatomically differentiated portfolios and strong physician-support capabilities can access higher-value demand than companies offering undifferentiated stents alone.
Regional Insights
North America and Europe are mature markets characterized by established therapeutic-endoscopy infrastructure, structured regulatory requirements, specialist referral networks and broad use of multinational brands. Competition emphasizes clinical evidence, predictable delivery, removability, adverse-event reduction and hospital-contract access. Boston Scientific, Cook Medical and Merit Medical Systems have established gastrointestinal or esophageal stent platforms, while ELLA-CS, ENDO-FLEX, Leufen Medical, AndraTec and other European specialists serve differentiated regional requirements. Product availability and approved indications vary by jurisdiction, making regulatory portfolio management important.
East Asia is both a major manufacturing base and an important innovation region. South Korea has a particularly strong specialist ecosystem represented by M.I.Tech, Taewoong Medical and Sewoon Medical, with extensive experience in covered nitinol and anatomically differentiated designs. Japan combines a sophisticated endoscopy market with strong distribution and clinical-development capabilities; Olympus acts as a product provider and channel partner for selected HANAROSTENT products manufactured by M.I.Tech rather than as an independent manufacturer of those specific stents. China is expanding through Micro-Tech Endoscopy, Jiangsu Vedkang, Changzhou Zhiye Medical Instrument Research Institute, Anrei Medical and other domestic manufacturers. India, Türkiye and other emerging production locations contribute through Mitra Industries and INVAMED, while demand growth depends on hospital access, physician training and local registration.
Competitive Landscape Analysis
The competitive landscape includes multinational endoscopy companies, specialist gastrointestinal-stent manufacturers and regional OEM or product providers. Boston Scientific and Cook Medical maintain broad anatomically differentiated portfolios: WallFlex covers esophageal, duodenal, colonic and biliary applications, while Cook’s Evolution platform covers esophageal, duodenal, colonic and biliary strictures with controlled-release functionality. Merit Medical Systems is more concentrated in fully covered esophageal products such as EndoMAXX and ALIMAXX-ES. M.I.Tech and Taewoong Medical are important Korean specialists; Taewoong’s Niti-S portfolio spans esophageal, pyloric and duodenal, colonic, biliary, pancreatic and lumen-apposing products, making its omission from the initial company list material. Micro-Tech Endoscopy provides esophageal, duodenal, colorectal and biliary systems and is an important Chinese globalizing supplier. ELLA-CS, ENDO-FLEX, Leufen Medical, INVAMED, AndraTec, Sewoon Medical, Jiangsu Vedkang, Changzhou Zhiye, Anrei Medical and Mitra Industries form the extended specialist pool, subject to product-level registration and current manufacturing verification in each target market. Olympus should be classified as a product provider and distributor for relevant M.I.Tech HANAROSTENT products to avoid double counting. Competition centers on deployment accuracy, force balance, migration prevention, covering integrity, clinical evidence, regulatory breadth and physician access rather than price alone.
Report Scope
This definitive report equips business leaders, decision-makers, and stakeholders with a 360° view of the global Digestive Tract Stent market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2021–2025) and delivers forecasts through 2032, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customer distribution pattern.
Granular regional insights cover five major markets (North America, Europe, APAC, South America, and MEA) with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers (sales volume, revenue, margins, pricing strategies, and major customers) and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Olympus Corporation
Boston Scientific
Cook Medical
ELLA-CS, s.r.o.
Micro-Tech Endoscopy
M.I.Tech
Sewoon Medical
Merit Medical Systems
ENDO-FLEX GmbH
Leufen Medical
INVAMED
Jiangsu Vedkang Medical Science and Technology
Changzhou Zhiye Medical Instrument Research Institute
Mitra Industries Private Limited
Anrei medical (hz)
AndraTec
Segment by Type
Esophageal Stent
Intestinal Stent
Other
Segment by Material
Metal Stents
Plastic Stents
Biodegradable Stents
Segment by Film Covered Structure
Covered Stent
Uncovered Stent
Segment by Diameter
Diameter 16 mm
Diameter 18 mm
Diameter 20 mm
Diameter 22 mm
Diameter 25 mm
Segment by Application
Benign Gastrointestinal Stricture
Malignant Gastrointestinal Stricture
Gastrointestinal Obstruction
Gastrointestinal Perforation
Other
Sales by Region
North America
U.S.
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
China Taiwan
Southeast Asia (Indonesia, Vietnam, Thailand)
Europe
Germany
France
U.K.
Italy
Russia
Central and South America
Brazil
Argentina
Rest of Central and South America
Middle East, Africa
Turkey
Egypt
GCC Countries
South Africa
Chapter Outline
Chapter 1: Defines the Digestive Tract Stent study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential
Chapter 2: Offers current market state, projects global revenue and sales to 2032, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape: ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves
Chapter 4: Unlocks high margin product segments: compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities: evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application
Chapter 6: North America: breaks down sales and revenue by Application and country, profiles key manufacturers and assesses growth drivers and barriers
Chapter 7: Europe: analyses regional sales, revenue and market by Application and manufacturers, flagging drivers and barriers
Chapter 8: Asia Pacific: quantifies sales and revenue by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas
Chapter 9: Central & South America: measures sales and revenue by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges
Chapter 10: Middle East and Africa: evaluates sales and revenue by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth: details product specs, sales, revenue, margins; top manufactures 2025 sales breakdowns by product type, by Application, by sales region SWOT analysis, and recent strategic developments
Chapter 12: Supply chain: analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles
Chapter 13: Market dynamics: explores drivers, restraints, regulatory impacts, and risk mitigation strategies
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Allocate capital strategically to high growth regions (Chapters 6-10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

ページTOPに戻る

Table of Contents

1 Study Coverage
1.1 Introduction to Digestive Tract Stent: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Digestive Tract Stent Market Size by Type, 2021 vs 2025 vs 2032
1.2.2 Esophageal Stent
1.2.3 Intestinal Stent
1.2.4 Other
1.3 Market Segmentation by Material
1.3.1 Global Digestive Tract Stent Market Size by Material, 2021 vs 2025 vs 2032
1.3.2 Metal Stents
1.3.3 Plastic Stents
1.3.4 Biodegradable Stents
1.4 Market Segmentation by Film Covered Structure
1.4.1 Global Digestive Tract Stent Market Size by Film Covered Structure, 2021 vs 2025 vs 2032
1.4.2 Covered Stent
1.4.3 Uncovered Stent
1.5 Market Segmentation by Diameter
1.5.1 Global Digestive Tract Stent Market Size by Diameter, 2021 vs 2025 vs 2032
1.5.2 Diameter 16 mm
1.5.3 Diameter 18 mm
1.5.4 Diameter 20 mm
1.5.5 Diameter 22 mm
1.5.6 Diameter 25 mm
1.6 Market Segmentation by Application
1.6.1 Global Digestive Tract Stent Market Size by Application, 2021 vs 2025 vs 2032
1.6.2 Benign Gastrointestinal Stricture
1.6.3 Malignant Gastrointestinal Stricture
1.6.4 Gastrointestinal Obstruction
1.6.5 Gastrointestinal Perforation
1.6.6 Other
1.7 Assumptions and Limitations
1.8 Study Objectives
1.9 Years Considered

2 Executive Summary
2.1 Global Digestive Tract Stent Revenue Estimates and Forecasts (2021-2032)
2.2 Global Digestive Tract Stent Revenue by Region
2.2.1 Revenue Comparison: 2021 vs 2025 vs 2032
2.2.2 Historical and Forecasted Revenue by Region (2021-2032)
2.2.3 Global Revenue-Based Market Share by Region (2021-2032)
2.3 Global Digestive Tract Stent Sales Estimates and Forecasts (2021-2032)
2.4 Global Digestive Tract Stent Sales by Region
2.4.1 Sales Comparison: 2021 vs 2025 vs 2032
2.4.2 Historical and Forecasted Sales by Region (2021-2032)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2021-2032)

3 Competitive Landscape
3.1 Global Digestive Tract Stent Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2021-2026)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2025)
3.2 Global Digestive Tract Stent Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2021-2026)
3.2.2 Global Key Manufacturer Revenue Ranking (2024 vs. 2025)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2021 vs 2025)
3.3.2 Manufacturer-Level Price Trends (2021-2026)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Key Manufacturers Market Share by Product Type
3.5.1 Esophageal Stent: Market Share by Key Manufacturers
3.5.2 Intestinal Stent: Market Share by Key Manufacturers
3.5.3 Other: Market Share by Key Manufacturers
3.6 Global Digestive Tract Stent Market Concentration and Dynamics
3.6.1 Global Market Concentration
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Product Segmentation
4.1 Global Digestive Tract Stent Sales Performance by Type
4.1.1 Global Digestive Tract Stent Sales Volume by Type (2021-2032)
4.1.2 Global Digestive Tract Stent Revenue by Type (2021-2032)
4.1.3 Global Average Selling Price (ASP) Trends by Type (2021-2032)
4.2 Global Digestive Tract Stent Sales Performance by Material
4.2.1 Global Digestive Tract Stent Sales Volume by Material (2021-2032)
4.2.2 Global Digestive Tract Stent Revenue by Material (2021-2032)
4.2.3 Global Average Selling Price (ASP) Trends by Material (2021-2032)
4.3 Global Digestive Tract Stent Sales Performance by Film Covered Structure
4.3.1 Global Digestive Tract Stent Sales Volume by Film Covered Structure (2021-2032)
4.3.2 Global Digestive Tract Stent Revenue by Film Covered Structure (2021-2032)
4.3.3 Global Average Selling Price (ASP) Trends by Film Covered Structure (2021-2032)
4.4 Global Digestive Tract Stent Sales Performance by Diameter
4.4.1 Global Digestive Tract Stent Sales Volume by Diameter (2021-2032)
4.4.2 Global Digestive Tract Stent Revenue by Diameter (2021-2032)
4.4.3 Global Average Selling Price (ASP) Trends by Diameter (2021-2032)
4.5 Product Technology Differentiation
4.6 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.6.1 High-Growth Niches and Adoption Drivers
4.6.2 Profitability Hotspots and Cost Drivers
4.6.3 Substitution Threats

5 Downstream Applications and Customers
5.1 Global Digestive Tract Stent Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2021-2032)
5.1.2 Global Sales Market Share by Application (2021-2032)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Digestive Tract Stent Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2021-2032)
5.2.2 Revenue-Based Market Share by Application (2021-2032)
5.3 Global Pricing Dynamics by Application (2021-2032)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application

6 North America
6.1 North America Sales Volume and Revenue (2021-2032)
6.2 North America Key Manufacturers Sales Revenue in 2025
6.3 North America Digestive Tract Stent Sales and Revenue by Application (2021-2032)
6.4 North America Growth Accelerators and Market Barriers
6.5 North America Digestive Tract Stent Market Size by Country
6.5.1 North America Revenue by Country
6.5.2 North America Sales Trends by Country
6.5.3 US
6.5.4 Canada
6.5.5 Mexico

7 Europe
7.1 Europe Sales Volume and Revenue (2021-2032)
7.2 Europe Key Manufacturers Sales Revenue in 2025
7.3 Europe Digestive Tract Stent Sales and Revenue by Application (2021-2032)
7.4 Europe Growth Accelerators and Market Barriers
7.5 Europe Digestive Tract Stent Market Size by Country
7.5.1 Europe Revenue by Country
7.5.2 Europe Sales Trends by Country
7.5.3 Germany
7.5.4 France
7.5.5 U.K.
7.5.6 Italy
7.5.7 Russia

8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2021-2032)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2025
8.3 Asia-Pacific Digestive Tract Stent Sales and Revenue by Application (2021-2032)
8.4 Asia-Pacific Digestive Tract Stent Market Size by Region
8.4.1 Asia-Pacific Revenue by Region
8.4.2 Asia-Pacific Sales Trends by Region
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Southeast Asia
8.6.1 Southeast Asia Revenue by Country (2021 vs 2025 vs 2032)
8.6.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.7 China
8.8 Japan
8.9 South Korea
8.10 China Taiwan
8.11 India

9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2021-2032)
9.2 Central and South America Key Manufacturers Sales Revenue in 2025
9.3 Central and South America Digestive Tract Stent Sales and Revenue by Application (2021-2032)
9.4 Central and South America Investment Opportunities and Key Challenges
9.5 Central and South America Digestive Tract Stent Market Size by Country
9.5.1 Central and South America Revenue Trends by Country (2021 vs 2025 vs 2032)
9.5.2 Brazil
9.5.3 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2021-2032)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2025
10.3 Middle East and Africa Digestive Tract Stent Sales and Revenue by Application (2021-2032)
10.4 Middle East and Africa Investment Opportunities and Key Challenges
10.5 Middle East and Africa Digestive Tract Stent Market Size by Country
10.5.1 Middle East and Africa Revenue Trends by Country (2021 vs 2025 vs 2032)
10.5.2 GCC Countries
10.5.3 Turkey
10.5.4 Egypt
10.5.5 South Africa

11 Corporate Profile
11.1 Olympus Corporation
11.1.1 Olympus Corporation Corporation Information
11.1.2 Olympus Corporation Business Overview
11.1.3 Olympus Corporation Digestive Tract Stent Product Models, Descriptions and Specifications
11.1.4 Olympus Corporation Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.1.5 Olympus Corporation Digestive Tract Stent Sales by Product in 2025
11.1.6 Olympus Corporation Digestive Tract Stent Sales by Application in 2025
11.1.7 Olympus Corporation Digestive Tract Stent Sales by Geographic Area in 2025
11.1.8 Olympus Corporation Digestive Tract Stent SWOT Analysis
11.1.9 Olympus Corporation Recent Developments
11.2 Boston Scientific
11.2.1 Boston Scientific Corporation Information
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Digestive Tract Stent Product Models, Descriptions and Specifications
11.2.4 Boston Scientific Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.2.5 Boston Scientific Digestive Tract Stent Sales by Product in 2025
11.2.6 Boston Scientific Digestive Tract Stent Sales by Application in 2025
11.2.7 Boston Scientific Digestive Tract Stent Sales by Geographic Area in 2025
11.2.8 Boston Scientific Digestive Tract Stent SWOT Analysis
11.2.9 Boston Scientific Recent Developments
11.3 Cook Medical
11.3.1 Cook Medical Corporation Information
11.3.2 Cook Medical Business Overview
11.3.3 Cook Medical Digestive Tract Stent Product Models, Descriptions and Specifications
11.3.4 Cook Medical Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.3.5 Cook Medical Digestive Tract Stent Sales by Product in 2025
11.3.6 Cook Medical Digestive Tract Stent Sales by Application in 2025
11.3.7 Cook Medical Digestive Tract Stent Sales by Geographic Area in 2025
11.3.8 Cook Medical Digestive Tract Stent SWOT Analysis
11.3.9 Cook Medical Recent Developments
11.4 ELLA-CS, s.r.o.
11.4.1 ELLA-CS, s.r.o. Corporation Information
11.4.2 ELLA-CS, s.r.o. Business Overview
11.4.3 ELLA-CS, s.r.o. Digestive Tract Stent Product Models, Descriptions and Specifications
11.4.4 ELLA-CS, s.r.o. Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.4.5 ELLA-CS, s.r.o. Digestive Tract Stent Sales by Product in 2025
11.4.6 ELLA-CS, s.r.o. Digestive Tract Stent Sales by Application in 2025
11.4.7 ELLA-CS, s.r.o. Digestive Tract Stent Sales by Geographic Area in 2025
11.4.8 ELLA-CS, s.r.o. Digestive Tract Stent SWOT Analysis
11.4.9 ELLA-CS, s.r.o. Recent Developments
11.5 Micro-Tech Endoscopy
11.5.1 Micro-Tech Endoscopy Corporation Information
11.5.2 Micro-Tech Endoscopy Business Overview
11.5.3 Micro-Tech Endoscopy Digestive Tract Stent Product Models, Descriptions and Specifications
11.5.4 Micro-Tech Endoscopy Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.5.5 Micro-Tech Endoscopy Digestive Tract Stent Sales by Product in 2025
11.5.6 Micro-Tech Endoscopy Digestive Tract Stent Sales by Application in 2025
11.5.7 Micro-Tech Endoscopy Digestive Tract Stent Sales by Geographic Area in 2025
11.5.8 Micro-Tech Endoscopy Digestive Tract Stent SWOT Analysis
11.5.9 Micro-Tech Endoscopy Recent Developments
11.6 M.I.Tech
11.6.1 M.I.Tech Corporation Information
11.6.2 M.I.Tech Business Overview
11.6.3 M.I.Tech Digestive Tract Stent Product Models, Descriptions and Specifications
11.6.4 M.I.Tech Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.6.5 M.I.Tech Recent Developments
11.7 Sewoon Medical
11.7.1 Sewoon Medical Corporation Information
11.7.2 Sewoon Medical Business Overview
11.7.3 Sewoon Medical Digestive Tract Stent Product Models, Descriptions and Specifications
11.7.4 Sewoon Medical Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.7.5 Sewoon Medical Recent Developments
11.8 Merit Medical Systems
11.8.1 Merit Medical Systems Corporation Information
11.8.2 Merit Medical Systems Business Overview
11.8.3 Merit Medical Systems Digestive Tract Stent Product Models, Descriptions and Specifications
11.8.4 Merit Medical Systems Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.8.5 Merit Medical Systems Recent Developments
11.9 ENDO-FLEX GmbH
11.9.1 ENDO-FLEX GmbH Corporation Information
11.9.2 ENDO-FLEX GmbH Business Overview
11.9.3 ENDO-FLEX GmbH Digestive Tract Stent Product Models, Descriptions and Specifications
11.9.4 ENDO-FLEX GmbH Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.9.5 ENDO-FLEX GmbH Recent Developments
11.10 Leufen Medical
11.10.1 Leufen Medical Corporation Information
11.10.2 Leufen Medical Business Overview
11.10.3 Leufen Medical Digestive Tract Stent Product Models, Descriptions and Specifications
11.10.4 Leufen Medical Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.10.5 Leufen Medical Recent Developments
11.11 INVAMED
11.11.1 INVAMED Corporation Information
11.11.2 INVAMED Business Overview
11.11.3 INVAMED Digestive Tract Stent Product Models, Descriptions and Specifications
11.11.4 INVAMED Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.11.5 INVAMED Recent Developments
11.12 Jiangsu Vedkang Medical Science and Technology
11.12.1 Jiangsu Vedkang Medical Science and Technology Corporation Information
11.12.2 Jiangsu Vedkang Medical Science and Technology Business Overview
11.12.3 Jiangsu Vedkang Medical Science and Technology Digestive Tract Stent Product Models, Descriptions and Specifications
11.12.4 Jiangsu Vedkang Medical Science and Technology Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.12.5 Jiangsu Vedkang Medical Science and Technology Recent Developments
11.13 Changzhou Zhiye Medical Instrument Research Institute
11.13.1 Changzhou Zhiye Medical Instrument Research Institute Corporation Information
11.13.2 Changzhou Zhiye Medical Instrument Research Institute Business Overview
11.13.3 Changzhou Zhiye Medical Instrument Research Institute Digestive Tract Stent Product Models, Descriptions and Specifications
11.13.4 Changzhou Zhiye Medical Instrument Research Institute Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.13.5 Changzhou Zhiye Medical Instrument Research Institute Recent Developments
11.14 Mitra Industries Private Limited
11.14.1 Mitra Industries Private Limited Corporation Information
11.14.2 Mitra Industries Private Limited Business Overview
11.14.3 Mitra Industries Private Limited Digestive Tract Stent Product Models, Descriptions and Specifications
11.14.4 Mitra Industries Private Limited Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.14.5 Mitra Industries Private Limited Recent Developments
11.15 Anrei medical (hz)
11.15.1 Anrei medical (hz) Corporation Information
11.15.2 Anrei medical (hz) Business Overview
11.15.3 Anrei medical (hz) Digestive Tract Stent Product Models, Descriptions and Specifications
11.15.4 Anrei medical (hz) Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.15.5 Anrei medical (hz) Recent Developments
11.16 AndraTec
11.16.1 AndraTec Corporation Information
11.16.2 AndraTec Business Overview
11.16.3 AndraTec Digestive Tract Stent Product Models, Descriptions and Specifications
11.16.4 AndraTec Digestive Tract Stent Sales, Price, Revenue and Gross Margin (2021-2026)
11.16.5 AndraTec Recent Developments

12 Value Chain and Supply-Chain Analysis
12.1 Digestive Tract Stent Industry Chain
12.2 Digestive Tract Stent Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Digestive Tract Stent Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2021-2032)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Digestive Tract Stent Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors

13 Digestive Tract Stent Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
13.4 Impact of U.S. Tariffs

14 Key Findings in the Global Digestive Tract Stent Study

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Global Digestive Tract Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Table 2. Global Digestive Tract Stent Market Size Growth Rate by Material, 2021 vs 2025 vs 2032 (US$ Million)
Table 3. Global Digestive Tract Stent Market Size Growth Rate by Film Covered Structure, 2021 vs 2025 vs 2032 (US$ Million)
Table 4. Global Digestive Tract Stent Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Table 5. Global Digestive Tract Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Table 6. Global Digestive Tract Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 7. Global Digestive Tract Stent Revenue by Region (US$ Million), 2021-2026
Table 8. Global Digestive Tract Stent Revenue by Region (US$ Million), 2027-2032
Table 9. Global Digestive Tract Stent Sales Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Table 10. Global Digestive Tract Stent Sales by Region (K Units), 2021-2026
Table 11. Global Digestive Tract Stent Sales by Region (K Units), 2027-2032
Table 12. Emerging Market Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 13. Global Digestive Tract Stent Sales by Manufacturers (K Units), 2021-2026
Table 14. Global Digestive Tract Stent Sales Share by Manufacturers (2021-2026)
Table 15. Global Digestive Tract Stent Revenue by Manufacturers (US$ Million), 2021-2026
Table 16. Global Digestive Tract Stent Revenue-Based Market Share by Manufacturers (2021-2026)
Table 17. Global Key Manufacturers’Ranking Shift (2024 vs. 2025) (Based on Revenue)
Table 18. Global Manufacturer by Tier (Tier 1, Tier 2, and Tier 3), based on Digestive Tract Stent Revenue, 2025
Table 19. Global Digestive Tract Stent Average Gross Margin (%) by Manufacturer (2021 vs 2025)
Table 20. Global Digestive Tract Stent Average Selling Price (ASP) by Manufacturers (US$/Unit), 2021-2026
Table 21. Key Manufacturers Digestive Tract Stent Manufacturing Base and Headquarters
Table 22. Global Digestive Tract Stent Market Concentration Ratio (CR5)
Table 23. Key Market Entrant/Exit (2021-2025) – Drivers & Impact Analysis
Table 24. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 25. Global Digestive Tract Stent Sales Volume by Type (K Units), 2021-2026
Table 26. Global Digestive Tract Stent Sales Volume by Type (K Units), 2027-2032
Table 27. Global Digestive Tract Stent Revenue by Type (US$ Million), 2021-2026
Table 28. Global Digestive Tract Stent Revenue by Type (US$ Million), 2027-2032
Table 29. Global Digestive Tract Stent Sales Volume by Material (K Units), 2021-2026
Table 30. Global Digestive Tract Stent Sales Volume by Material (K Units), 2027-2032
Table 31. Global Digestive Tract Stent Revenue by Material (US$ Million), 2021-2026
Table 32. Global Digestive Tract Stent Revenue by Material (US$ Million), 2027-2032
Table 33. Global Digestive Tract Stent Sales Volume by Film Covered Structure (K Units), 2021-2026
Table 34. Global Digestive Tract Stent Sales Volume by Film Covered Structure (K Units), 2027-2032
Table 35. Global Digestive Tract Stent Revenue by Film Covered Structure (US$ Million), 2021-2026
Table 36. Global Digestive Tract Stent Revenue by Film Covered Structure (US$ Million), 2027-2032
Table 37. Global Digestive Tract Stent Sales Volume by Diameter (K Units), 2021-2026
Table 38. Global Digestive Tract Stent Sales Volume by Diameter (K Units), 2027-2032
Table 39. Global Digestive Tract Stent Revenue by Diameter (US$ Million), 2021-2026
Table 40. Global Digestive Tract Stent Revenue by Diameter (US$ Million), 2027-2032
Table 41. Technical Specifications by Key Product Type
Table 42. Global Digestive Tract Stent Sales by Application (K Units), 2021-2026
Table 43. Global Digestive Tract Stent Sales by Application (K Units), 2027-2032
Table 44. Digestive Tract Stent High-Growth Sectors Demand CAGR (2026-2032)
Table 45. Global Digestive Tract Stent Revenue by Application (US$ Million), 2021-2026
Table 46. Global Digestive Tract Stent Revenue by Application (US$ Million), 2027-2032
Table 47. Top Customers by Region
Table 48. Top Customers by Application
Table 49. North America Digestive Tract Stent Growth Accelerators and Market Barriers
Table 50. North America Digestive Tract Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 51. North America Digestive Tract Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 52. Europe Digestive Tract Stent Growth Accelerators and Market Barriers
Table 53. Europe Digestive Tract Stent Revenue Grow Rate (CAGR) by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 54. Europe Digestive Tract Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 55. Asia-Pacific Digestive Tract Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 56. Asia-Pacific Digestive Tract Stent Sales (K Units) by Country (2021 vs 2025 vs 2032)
Table 57. Asia-Pacific Digestive Tract Stent Growth Accelerators and Market Barriers
Table 58. Southeast Asia Digestive Tract Stent Revenue Grow Rate (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 59. Central and South America Digestive Tract Stent Investment Opportunities and Key Challenges
Table 60. Central and South America Digestive Tract Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 61. Middle East and Africa Digestive Tract Stent Investment Opportunities and Key Challenges
Table 62. Middle East and Africa Digestive Tract Stent Revenue Grow Rate (CAGR) by Country (2021 vs 2025 vs 2032) (US$ Million)
Table 63. Olympus Corporation Corporation Information
Table 64. Olympus Corporation Description and Major Businesses
Table 65. Olympus Corporation Product Models, Descriptions and Specifications
Table 66. Olympus Corporation Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 67. Olympus Corporation Sales Value Proportion by Product in 2025
Table 68. Olympus Corporation Sales Value Proportion by Application in 2025
Table 69. Olympus Corporation Sales Value Proportion by Geographic Area in 2025
Table 70. Olympus Corporation Digestive Tract Stent SWOT Analysis
Table 71. Olympus Corporation Recent Developments
Table 72. Boston Scientific Corporation Information
Table 73. Boston Scientific Description and Major Businesses
Table 74. Boston Scientific Product Models, Descriptions and Specifications
Table 75. Boston Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Boston Scientific Sales Value Proportion by Product in 2025
Table 77. Boston Scientific Sales Value Proportion by Application in 2025
Table 78. Boston Scientific Sales Value Proportion by Geographic Area in 2025
Table 79. Boston Scientific Digestive Tract Stent SWOT Analysis
Table 80. Boston Scientific Recent Developments
Table 81. Cook Medical Corporation Information
Table 82. Cook Medical Description and Major Businesses
Table 83. Cook Medical Product Models, Descriptions and Specifications
Table 84. Cook Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 85. Cook Medical Sales Value Proportion by Product in 2025
Table 86. Cook Medical Sales Value Proportion by Application in 2025
Table 87. Cook Medical Sales Value Proportion by Geographic Area in 2025
Table 88. Cook Medical Digestive Tract Stent SWOT Analysis
Table 89. Cook Medical Recent Developments
Table 90. ELLA-CS, s.r.o. Corporation Information
Table 91. ELLA-CS, s.r.o. Description and Major Businesses
Table 92. ELLA-CS, s.r.o. Product Models, Descriptions and Specifications
Table 93. ELLA-CS, s.r.o. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. ELLA-CS, s.r.o. Sales Value Proportion by Product in 2025
Table 95. ELLA-CS, s.r.o. Sales Value Proportion by Application in 2025
Table 96. ELLA-CS, s.r.o. Sales Value Proportion by Geographic Area in 2025
Table 97. ELLA-CS, s.r.o. Digestive Tract Stent SWOT Analysis
Table 98. ELLA-CS, s.r.o. Recent Developments
Table 99. Micro-Tech Endoscopy Corporation Information
Table 100. Micro-Tech Endoscopy Description and Major Businesses
Table 101. Micro-Tech Endoscopy Product Models, Descriptions and Specifications
Table 102. Micro-Tech Endoscopy Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 103. Micro-Tech Endoscopy Sales Value Proportion by Product in 2025
Table 104. Micro-Tech Endoscopy Sales Value Proportion by Application in 2025
Table 105. Micro-Tech Endoscopy Sales Value Proportion by Geographic Area in 2025
Table 106. Micro-Tech Endoscopy Digestive Tract Stent SWOT Analysis
Table 107. Micro-Tech Endoscopy Recent Developments
Table 108. M.I.Tech Corporation Information
Table 109. M.I.Tech Description and Major Businesses
Table 110. M.I.Tech Product Models, Descriptions and Specifications
Table 111. M.I.Tech Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 112. M.I.Tech Recent Developments
Table 113. Sewoon Medical Corporation Information
Table 114. Sewoon Medical Description and Major Businesses
Table 115. Sewoon Medical Product Models, Descriptions and Specifications
Table 116. Sewoon Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 117. Sewoon Medical Recent Developments
Table 118. Merit Medical Systems Corporation Information
Table 119. Merit Medical Systems Description and Major Businesses
Table 120. Merit Medical Systems Product Models, Descriptions and Specifications
Table 121. Merit Medical Systems Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 122. Merit Medical Systems Recent Developments
Table 123. ENDO-FLEX GmbH Corporation Information
Table 124. ENDO-FLEX GmbH Description and Major Businesses
Table 125. ENDO-FLEX GmbH Product Models, Descriptions and Specifications
Table 126. ENDO-FLEX GmbH Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 127. ENDO-FLEX GmbH Recent Developments
Table 128. Leufen Medical Corporation Information
Table 129. Leufen Medical Description and Major Businesses
Table 130. Leufen Medical Product Models, Descriptions and Specifications
Table 131. Leufen Medical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 132. Leufen Medical Recent Developments
Table 133. INVAMED Corporation Information
Table 134. INVAMED Description and Major Businesses
Table 135. INVAMED Product Models, Descriptions and Specifications
Table 136. INVAMED Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 137. INVAMED Recent Developments
Table 138. Jiangsu Vedkang Medical Science and Technology Corporation Information
Table 139. Jiangsu Vedkang Medical Science and Technology Description and Major Businesses
Table 140. Jiangsu Vedkang Medical Science and Technology Product Models, Descriptions and Specifications
Table 141. Jiangsu Vedkang Medical Science and Technology Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 142. Jiangsu Vedkang Medical Science and Technology Recent Developments
Table 143. Changzhou Zhiye Medical Instrument Research Institute Corporation Information
Table 144. Changzhou Zhiye Medical Instrument Research Institute Description and Major Businesses
Table 145. Changzhou Zhiye Medical Instrument Research Institute Product Models, Descriptions and Specifications
Table 146. Changzhou Zhiye Medical Instrument Research Institute Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 147. Changzhou Zhiye Medical Instrument Research Institute Recent Developments
Table 148. Mitra Industries Private Limited Corporation Information
Table 149. Mitra Industries Private Limited Description and Major Businesses
Table 150. Mitra Industries Private Limited Product Models, Descriptions and Specifications
Table 151. Mitra Industries Private Limited Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 152. Mitra Industries Private Limited Recent Developments
Table 153. Anrei medical (hz) Corporation Information
Table 154. Anrei medical (hz) Description and Major Businesses
Table 155. Anrei medical (hz) Product Models, Descriptions and Specifications
Table 156. Anrei medical (hz) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 157. Anrei medical (hz) Recent Developments
Table 158. AndraTec Corporation Information
Table 159. AndraTec Description and Major Businesses
Table 160. AndraTec Product Models, Descriptions and Specifications
Table 161. AndraTec Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 162. AndraTec Recent Developments
Table 163. Key Raw Materials Distribution
Table 164. Raw Materials Key Suppliers
Table 165. Critical Raw Material Supplier Concentration (2025) & Risk Index
Table 166. Milestones in Production Technology Evolution
Table 167. Distributors List
Table 168. Market Trends and Market Evolution
Table 169. Market Drivers and Opportunities
Table 170. Market Challenges, Risks, and Restraints
Table 171. Research Programs/Design for This Report
Table 172. Key Data Information from Secondary Sources
Table 173. Key Data Information from Primary Sources

List of Figures
Figure 1. Digestive Tract Stent Product Picture
Figure 2. Global Digestive Tract Stent Market Size Growth Rate by Type, 2021 vs 2025 vs 2032 (US$ Million)
Figure 3. Esophageal Stent Product Picture
Figure 4. Intestinal Stent Product Picture
Figure 5. Other Product Picture
Figure 6. Global Digestive Tract Stent Market Size Growth Rate by Material, 2021 vs 2025 vs 2032 (US$ Million)
Figure 7. Metal Stents Product Picture
Figure 8. Plastic Stents Product Picture
Figure 9. Biodegradable Stents Product Picture
Figure 10. Global Digestive Tract Stent Market Size Growth Rate by Film Covered Structure, 2021 vs 2025 vs 2032 (US$ Million)
Figure 11. Covered Stent Product Picture
Figure 12. Uncovered Stent Product Picture
Figure 13. Global Digestive Tract Stent Market Size Growth Rate by Diameter, 2021 vs 2025 vs 2032 (US$ Million)
Figure 14. Diameter 16 mm Product Picture
Figure 15. Diameter 18 mm Product Picture
Figure 16. Diameter 20 mm Product Picture
Figure 17. Diameter 22 mm Product Picture
Figure 18. Diameter 25 mm Product Picture
Figure 19. Global Digestive Tract Stent Market Size Growth Rate by Application, 2021 vs 2025 vs 2032 (US$ Million)
Figure 20. Benign Gastrointestinal Stricture
Figure 21. Malignant Gastrointestinal Stricture
Figure 22. Gastrointestinal Obstruction
Figure 23. Gastrointestinal Perforation
Figure 24. Other
Figure 25. Digestive Tract Stent Report Years Considered
Figure 26. Global Digestive Tract Stent Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 27. Global Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 28. Global Digestive Tract Stent Revenue (CAGR) by Region: 2021 vs 2025 vs 2032 (US$ Million)
Figure 29. Global Digestive Tract Stent Revenue-Based Market Share by Region (2021-2032)
Figure 30. Global Digestive Tract Stent Sales (K Units), 2021-2032
Figure 31. Global Digestive Tract Stent Sales (CAGR) by Region: 2021 vs 2025 vs 2032 (K Units)
Figure 32. Global Digestive Tract Stent Sales Market Share by Region (2021-2032)
Figure 33. Top 5 and Top 10 Manufacturers Digestive Tract Stent Sales Volume Market Share in 2025
Figure 34. Global Digestive Tract Stent Revenue-Based Market Share Ranking (2025)
Figure 35. Tier Distribution by Revenue Contribution (2021 vs 2025)
Figure 36. Esophageal Stent Revenue-Based Market Share by Manufacturer in 2025
Figure 37. Intestinal Stent Revenue-Based Market Share by Manufacturer in 2025
Figure 38. Other Revenue-Based Market Share by Manufacturer in 2025
Figure 39. Global Digestive Tract Stent Sales Volume-Based Market Share by Type (2021-2032)
Figure 40. Global Digestive Tract Stent Revenue-Based Market Share by Type (2021-2032)
Figure 41. Global Digestive Tract Stent ASP by Type (US$/Unit), 2021-2032
Figure 42. Global Digestive Tract Stent Sales Volume-Based Market Share by Material (2021-2032)
Figure 43. Global Digestive Tract Stent Revenue-Based Market Share by Material (2021-2032)
Figure 44. Global Digestive Tract Stent ASP by Material (US$/Unit), 2021-2032
Figure 45. Global Digestive Tract Stent Sales Volume-Based Market Share by Film Covered Structure (2021-2032)
Figure 46. Global Digestive Tract Stent Revenue-Based Market Share by Film Covered Structure (2021-2032)
Figure 47. Global Digestive Tract Stent ASP by Film Covered Structure (US$/Unit), 2021-2032
Figure 48. Global Digestive Tract Stent Sales Volume-Based Market Share by Diameter (2021-2032)
Figure 49. Global Digestive Tract Stent Revenue-Based Market Share by Diameter (2021-2032)
Figure 50. Global Digestive Tract Stent ASP by Diameter (US$/Unit), 2021-2032
Figure 51. Global Digestive Tract Stent Sales Market Share by Application (2021-2032)
Figure 52. Global Digestive Tract Stent Revenue-Based Market Share by Application (2021-2032)
Figure 53. Global Digestive Tract Stent ASP by Application (US$/Unit), 2021-2032
Figure 54. North America Digestive Tract Stent Sales YoY (K Units), 2021-2032
Figure 55. North America Digestive Tract Stent Revenue YoY (US$ Million), 2021-2032
Figure 56. North America Top 5 Manufacturers Digestive Tract Stent Sales Revenue (US$ Million) in 2025
Figure 57. North America Digestive Tract Stent Sales Volume (K Units) by Application (2021-2032)
Figure 58. North America Digestive Tract Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 59. US Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 60. Canada Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 61. Mexico Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 62. Europe Digestive Tract Stent Sales YoY (K Units), 2021-2032
Figure 63. Europe Digestive Tract Stent Revenue YoY (US$ Million), 2021-2032
Figure 64. Europe Top 5 Manufacturers Digestive Tract Stent Sales Revenue (US$ Million) in 2025
Figure 65. Europe Digestive Tract Stent Sales Volume (K Units) by Application (2021-2032)
Figure 66. Europe Digestive Tract Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 67. Germany Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 68. France Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 69. U.K. Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 70. Italy Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 71. Russia Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 72. Asia-Pacific Digestive Tract Stent Sales YoY (K Units), 2021-2032
Figure 73. Asia-Pacific Digestive Tract Stent Revenue YoY (US$ Million), 2021-2032
Figure 74. Asia-Pacific Top 8 Manufacturers Digestive Tract Stent Sales Revenue (US$ Million) in 2025
Figure 75. Asia-Pacific Digestive Tract Stent Sales Volume (K Units) by Application (2021-2032)
Figure 76. Asia-Pacific Digestive Tract Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 77. Indonesia Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 78. Japan Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 79. South Korea Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 80. China Taiwan Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 81. India Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 82. Central and South America Digestive Tract Stent Sales YoY (K Units), 2021-2032
Figure 83. Central and South America Digestive Tract Stent Revenue YoY (US$ Million), 2021-2032
Figure 84. Central and South America Top 5 Manufacturers Digestive Tract Stent Sales Revenue (US$ Million) in 2025
Figure 85. Central and South America Digestive Tract Stent Sales Volume (K Units) by Application (2021-2032)
Figure 86. Central and South America Digestive Tract Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 87. Brazil Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 88. Argentina Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 89. Middle East, and Africa Digestive Tract Stent Sales YoY (K Units), 2021-2032
Figure 90. Middle East and Africa Digestive Tract Stent Revenue YoY (US$ Million), 2021-2032
Figure 91. Middle East and Africa Top 5 Manufacturers Digestive Tract Stent Sales Revenue (US$ Million) in 2025
Figure 92. Middle East and Africa Digestive Tract Stent Sales Volume (K Units) by Application (2021-2032)
Figure 93. Middle East and Africa Digestive Tract Stent Sales Revenue (US$ Million) by Application (2021-2032)
Figure 94. GCC Countries Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 95. Turkey Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 96. Egypt Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 97. South Africa Digestive Tract Stent Revenue (US$ Million), 2021-2032
Figure 98. Digestive Tract Stent Industry Chain Mapping
Figure 99. Regional Digestive Tract Stent Manufacturing Base Distribution (%)
Figure 100. Global Digestive Tract Stent Production Market Share by Region (2021-2032)
Figure 101. Digestive Tract Stent Production Process
Figure 102. Regional Digestive Tract Stent Production Cost Structure
Figure 103. Channels of Distribution (Direct Vs Distribution)
Figure 104. Bottom-up and Top-down Approaches for This Report
Figure 105. Data Triangulation
Figure 106. Key Executives Interviewed